Is UNII-49717AWG6K Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use UNII-49717AWG6K? Is UNII-49717AWG6K safe for nursing mother and child? Does UNII-49717AWG6K extracts into breast milk? Does UNII-49717AWG6K has any long term or short term side effects on infants? Can UNII-49717AWG6K influence milk supply or can UNII-49717AWG6K decrease milk supply in lactating mothers?

Synthetic drug and nucleoside analogue which is structurally related to guanine with antiviral activity. It is used in infants and newborns for treatment of respiratory syncytial virus (RSV) and adenovirus. Along with interferon for treatment of hepatitis C (authorized on these cases from the 3 years of life). At latest update no published data on excretion into breast milk were found. Its large volume of distribution makes it unlikely that may occur the passage of significant amounts to the milk. Its low oral bioavailability hinder the passage toward infant’s plasma from ingested milk, except in preterm milk and immediate neonatal period, for which there may be an increased intestinal permeability. Since it is used as treatment on infants and its pharmacokinetic data are favorable, it should be regarded as compatible with breastfeeding for short-term exposures, however, to be cautiously used on long-term treatments.

UNII-49717AWG6K has not been studied in nursing mothers being treated for hepatitis C infection. However, UNII-49717AWG6K is given directly to infants by inhalation to treat respiratory syncytial virus (RSV) infection. The amount in milk is likely to be lower than the doses received by infants treated with UNII-49717AWG6K for RSV infection. Hepatitis C is not transmitted through breastmilk[1][2] and breastmilk has been shown to inactivate hepatitis C virus (HCV).[3][4] However, the Centers for Disease Control recommends that mothers with HCV infection should consider abstaining from breastfeeding if their nipples are cracked or bleeding. It is not clear if this warning would apply to mothers who are being treated for hepatitis C. Infants born to mothers with HCV infection should be tested for HCV infection; because maternal antibody is present for the first 18 months of life and before the infant mounts an immunologic response, nucleic acid testing is recommended.[1][2]